Science · 2018
Cancer immunotherapy using checkpoint blockade
Ribas A, Wolchok JD.
Show affiliations
- Ribas A — Department of Medicine, Division of Hematology-Oncology; Department of Surgery, Division of Surgical Oncology; and Department of Molecular and Medical Pharmacology, Jonsson Comprehensive Cancer Center and Parker Institute for Cancer Immunotherapy, University of California, Los Angeles, Los Angeles, CA 90095, USA. aribas@mednet.ucla.edu wolchokj@mskcc.org.
- Wolchok JD — Department of Medicine, Ludwig Center and Parker Institute for Cancer Immunotherapy at Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. aribas@mednet.ucla.edu wolchokj@mskcc.org.
31 read4 want to readRigor 3.0Novelty 3.5Impact 3.3Reprod. 3.1
Most-cited papers citing this
- Cell Mol Immunol · 2026 · cited by 1
- Chem Sci · 2026 · cited by 1
- Clin Transl Med · 2026 · cited by 1
- Nat Cancer · 2026 · cited by 1
- Front Oncol · 2025 · cited by 1
Log in to like, log, and share thoughts on this paper.
Discussion
Share your thoughts above to start a thread. Constructive feedback only — reply to and like others’ posts.
0
0
0
0
0
0
0
0